TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings
TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于提前归还可转债暂时补充流动资金的募集资金的公告 | 2026-05-11 | Chinese | |
| 2025年度独立董事述职报告（赖瀚琪） | 2026-03-23 | Chinese | |
| 董事、高级管理人员离职管理制度 | 2026-03-23 | Chinese | |
| 非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告 | 2026-03-23 | Chinese | |
| 董事会对独立董事独立性自查情况的专项报告 | 2026-03-23 | Chinese | |
| 2025年年度审计报告 | 2026-03-23 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45017242 | 关于提前归还可转债暂时补充流动资金的募集资金的公告 | 2026-05-11 | Chinese | ||
| 37015439 | 2025年度独立董事述职报告（赖瀚琪） | 2026-03-23 | Chinese | ||
| 37015436 | 董事、高级管理人员离职管理制度 | 2026-03-23 | Chinese | ||
| 37015427 | 非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告 | 2026-03-23 | Chinese | ||
| 37015412 | 董事会对独立董事独立性自查情况的专项报告 | 2026-03-23 | Chinese | ||
| 37015399 | 2025年年度审计报告 | 2026-03-23 | Chinese | ||
| 37015363 | 2025年年度报告摘要 | 2026-03-23 | Chinese | ||
| 37015358 | 2025年度财务决算报告 | 2026-03-23 | Chinese | ||
| 37015354 | 2025年度董事会工作报告 | 2026-03-23 | Chinese | ||
| 37015352 | 关于2026年度董事、高级管理人员薪酬方案的公告 | 2026-03-23 | Chinese | ||
| 37015348 | 2025年度独立董事述职报告（李桂生）-已离任 | 2026-03-23 | Chinese | ||
| 37015346 | 2025年度内部控制自我评价报告 | 2026-03-23 | Chinese | ||
| 37015330 | 募集资金存放、管理与使用情况审核报告 | 2026-03-23 | Chinese | ||
| 37015003 | 2025年度非经营性资金占用及其他关联资金往来情况汇总表 | 2026-03-23 | Chinese | ||
| 37015001 | 章程修正案 | 2026-03-23 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TEYI PHARMACEUTICAL GROUP CO.,LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54743/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54743 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54743 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54743 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54743}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TEYI PHARMACEUTICAL GROUP CO.,LTD (id: 54743)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.